CYP2C19 participates in tolbutamide hydroxylation by human liver microsomes.
暂无分享,去创建一个
M. Wester | J. Lasker | J M Lasker | J L Raucy | M R Wester | E F Johnson | J. Raucy | E. F. Johnson | Eric F Johnson | M. R. Wester
[1] F. Guengerich,et al. Hepatic metabolism of tolbutamide: characterization of the form of cytochrome P-450 involved in methyl hydroxylation and relationship to in vivo disposition. , 1987, The Journal of pharmacology and experimental therapeutics.
[2] J. S. Miles,et al. Relative expression of cytochrome P450 isoenzymes in human liver and association with the metabolism of drugs and xenobiotics. , 1992, The Biochemical journal.
[3] G. Shenfield,et al. The role of the CYP2C9-Leu359 allelic variant in the tolbutamide polymorphism. , 1996, Pharmacogenetics.
[4] D. Greenblatt,et al. Relative quantities of catalytically active CYP 2C9 and 2C19 in human liver microsomes: application of the relative activity factor approach. , 1998, Journal of pharmaceutical sciences.
[5] P. Srivastava,et al. Separation of human liver microsomal tolbutamide hydroxylase and (S)-mephenytoin 4'-hydroxylase cytochrome P-450 enzymes. , 1991, Molecular pharmacology.
[6] L. Wienkers,et al. Relationships between the levels of cytochrome P4502C9 and its prototypic catalytic activities in human liver microsomes. , 1994, Drug metabolism and disposition: the biological fate of chemicals.
[7] A. Y. Lu,et al. Cytochrome P450 inhibitors. Evaluation of specificities in the in vitrometabolism of therapeutic agents by human liver microsomes. , 1995, Drug metabolism and disposition: the biological fate of chemicals.
[8] T. Kronbach,et al. Assay of mephenytoin metabolism in human liver microsomes by high-performance liquid chromatography. , 1985, Analytical biochemistry.
[9] J. Miners,et al. Tolbutamide and phenytoin hydroxylations by cDNA-expressed human liver cytochrome P4502C9. , 1991, Biochemical and biophysical research communications.
[10] M. Romkes,et al. Cloning and expression of complementary DNAs for multiple members of the human cytochrome P450IIC subfamily. , 1991, Biochemistry.
[11] J. P. Shea,et al. A convenient assay for mephenytoin 4-hydroxylase activity of human liver microsomal cytochrome P-450. , 1985, Analytical biochemistry.
[12] T. Shimada,et al. Human liver microsomal cytochrome P-450 mephenytoin 4-hydroxylase, a prototype of genetic polymorphism in oxidative drug metabolism. Purification and characterization of two similar forms involved in the reaction. , 1986, The Journal of biological chemistry.
[13] J. Lasker,et al. Isolation of P450 enzymes from human liver. , 1991, Methods in enzymology.
[14] T. Shimada,et al. Twenty years of biochemistry of human P450s: purification, expression, mechanism, and relevance to drugs. , 1998, Drug metabolism and disposition: the biological fate of chemicals.
[15] P. Poffenbarger,et al. Pharmacogenetics of Tolbutamide Metabolism in Humans , 1978, Diabetes.
[16] M. Wester,et al. Characterization of CYP2C19 and CYP2C9 from human liver: respective roles in microsomal tolbutamide, S-mephenytoin, and omeprazole hydroxylations. , 1998, Archives of biochemistry and biophysics.
[17] H. Yamazaki,et al. Relationship between CYP2C9 and 2C19 genotypes and tolbutamide methyl hydroxylation and S-mephenytoin 4'-hydroxylation activities in livers of Japanese and Caucasian populations. , 1997, Pharmacogenetics.
[18] T. Leemann,et al. Cytochrome P450TB (CYP2C): a major monooxygenase catalyzing diclofenac 4'-hydroxylation in human liver. , 1993, Life sciences.
[19] T. Richardson,et al. A universal approach to the expression of human and rabbit cytochrome P450s of the 2C subfamily in Escherichia coli. , 1995, Archives of biochemistry and biophysics.
[20] P. K. Smith,et al. Measurement of protein using bicinchoninic acid. , 1985, Analytical biochemistry.
[21] T. Omura,et al. THE CARBON MONOXIDE-BINDING PIGMENT OF LIVER MICROSOMES. I. EVIDENCE FOR ITS HEMOPROTEIN NATURE. , 1964, The Journal of biological chemistry.